Nuveen Fund Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-942
| Closed | -$381K | – | 98 |
|
|
2018
Q3 | $381K | Sell |
942
-851
| -47% | -$344K | 0.85% | 42 |
|
|
2018
Q2 | $619K | Sell |
1,793
-845
| -32% | -$292K | 0.76% | 40 |
|
|
2018
Q1 | $908K | Sell |
2,638
-168
| -6% | -$57.8K | 0.42% | 66 |
|
|
2017
Q4 | $1.06M | Sell |
2,806
-1,276
| -31% | -$480K | 0.31% | 85 |
|
|
2017
Q3 | $1.83M | Sell |
4,082
-566
| -12% | -$253K | 0.37% | 77 |
|
|
2017
Q2 | $2.28M | Sell |
4,648
-2,242
| -33% | -$1.1M | 0.36% | 82 |
|
|
2017
Q1 | $2.67M | Sell |
6,890
-469
| -6% | -$182K | 0.35% | 100 |
|
|
2016
Q4 | $2.7M | Sell |
7,359
-473
| -6% | -$174K | 0.39% | 88 |
|
|
2016
Q3 | $3.15M | Buy |
7,832
+251
| +3% | +$101K | 0.44% | 67 |
|
|
2016
Q2 | $2.65M | Buy |
+7,581
| New | +$2.65M | 0.41% | 78 |
|